Yahoo Web Search

Search results

  1. People also ask

  2. Apr 13, 2021 · Joint CDC and FDA Statement on Johnson & Johnson COVID-19 Vaccine. The following statement is attributed to Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and...

  3. Jan 6, 2022 · The Johnson & Johnson COVID-19 vaccine demonstrated a profile that showed durability of effectiveness up to 6 months for hospitalizations and ICU admissions across the study period, with a modest increase in breakthrough infections starting in month 4.

  4. Jan 20, 2022 · Estimated COVID-19 hospitalizations prevented during 180 days after administration of 1-dose Janssen (Johnson & Johnson) COVID-19 vaccine and 2-dose mRNA COVID-19 vaccine, number of cases of Guillain-Barré syndrome and thrombosis with thrombocytopenia syndrome cases expected per million Janssen vaccine doses administered and, number of ...

  5. Johnson & Johnson is testing a coronavirus vaccine known as JNJ-78436735 or Ad26.COV2.S. Clinical trials showed that a single dose of the vaccine had an efficacy rate of 72 percent in the...

  6. Oct 20, 2021 · NEW BRUNSWICK, N.J., October 20, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for a booster dose of the Johnson & Johnson COVID-19 vaccine for adults aged 18 and older at least two months following primary vaccination with single-shot J...

  7. Feb 27, 2021 · The FDA determined that Johnson & Johnson’s vaccine meets the criteria for safety and effectiveness and that there is clear evidence that it may prevent COVID-19, the agency said in a...

  8. Mar 5, 2021 · Coronavirus Updates. FDA Authorizes Johnson & Johnson's One-Shot COVID-19 Vaccine. Shots - Health News. COMIC: How One COVID-19 Nurse Navigates Anti-Mask Sentiment. Dr. Leana Wen, an...

  1. People also search for